CClinicalTrials.gg
CompletedNCT07648134Updated Jun 15, 2026

Virtual Reality for Pain Reduction During IUD Insertion

An interventional study of Virtual Reality in Pain During Intrauterine Device Insertion and Anxiety, sponsored by Tanta University. Completed at 1 site in Egypt. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-06-15.

Sponsored by Tanta University · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Registered 3 years 9 months after the study started (first participant enrolled Sep 2022, registered Jun 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Non-randomized
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

This study aims to evaluate the effectiveness of virtual reality (VR) as a non-pharmacological distraction intervention during intrauterine device (IUD) insertion. IUD insertion is commonly associated with pain and anxiety, which may negatively affect patient experience and acceptance of the procedure.

In this quasi-experimental study, women undergoing IUD insertion were allocated into two groups: a virtual reality group receiving immersive audiovisual distraction during the procedure and a control group receiving standard care. Pain intensity and anxiety levels were assessed and compared between the two groups.

The findings of this study are expected to support the use of VR as a safe, simple, and non-invasive method to reduce procedural pain and anxiety and improve patient satisfaction during IUD insertion.

Read the detailed description

This quasi-experimental pretest-posttest study with a non-equivalent control group was conducted to evaluate the effectiveness of virtual reality (VR) as a non-pharmacological distraction intervention during intrauterine device (IUD) insertion.

A total of 90 women undergoing IUD insertion were enrolled and allocated into two groups using clinic registration numbers: an intervention group (VR group) and a control group. The control group received standard care, including routine pre-procedural counseling and IUD insertion, while the intervention group received the same standard care in addition to a virtual reality-based intervention.

The VR intervention consisted of both pre-procedural and intra-procedural components. Before the procedure, participants viewed a structured educational video explaining the IUD insertion process. During the procedure, participants wore a head-mounted virtual reality device displaying immersive calming audiovisual content, such as natural landscapes accompanied by soft music, to provide distraction and reduce attention to procedural stimuli.

The primary outcome was pain intensity, assessed during IUD insertion using a Visual Analog Scale (VAS) ranging from 0 (no pain) to 10 (worst imaginable pain). Secondary outcomes included state anxiety, measured using the State-Trait Anxiety Inventory (STAI) State subscale (score range: 20-80, with higher scores indicating greater anxiety), and patient satisfaction with the procedure.

Outcome measures were assessed at baseline (immediately before the procedure) and immediately after IUD insertion. The study was conducted in a clinical setting at Tanta University, and ethical approval was obtained prior to data collection.

This study aims to provide evidence regarding the effectiveness of VR as a safe, non-invasive, and cost-effective intervention to reduce pain and anxiety and improve the overall patient experience during IUD insertion procedures.

02

Conditions studied

  • Pain During Intrauterine Device Insertion
  • Anxiety

Keywords

  • Virtual reality
  • Intrauterine device IUD insertion
  • Pain management
  • Anxiety
  • Patient satisfaction
  • Quasi-experimental
  • Non-pharmacological
03

In context

Anxiety Disorders

4,868 studies on the registry are indexed under Anxiety Disorders; 1,390 are open to participants now.

This study's enrollment of 90 is above the median of 80 across 4,174 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Tanta University is the lead sponsor of 963 studies on the registry; 304 are open to participants now.

Of its 16 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Women eligible for intrauterine device (IUD) insertion
  • Age between 18 and 45 years
  • Willing to participate and provide informed consent

Exclusion criteria

Exclusion Criteria:

  • Contraindications to IUD insertion
  • History of severe anxiety disorders
  • Previous adverse reaction to virtual reality
  • Refusal to participate
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
90 participants (actual)

Study arms

  • Experimental
    Virtual Reality

    Participants receive virtual reality distraction during intrauterine device insertion.

    Behavioral: Virtual Reality

  • No intervention
    Control Group

    Participants receive routine care during intrauterine device insertion without virtual reality.

Interventions

  • BehavioralVirtual Reality

    Use of virtual reality headset as a distraction method during IUD insertion.

06

What researchers measure

Primary outcomes

  1. Pain intensity measured using Visual Analog Scale (VAS)

    Pain intensity will be assessed using a Visual Analog Scale (VAS) ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain.

    Time frame: During IUD insertion procedure

Secondary outcomes

  1. State anxiety level measured by the State-Trait Anxiety Inventory (STAI) - State subscale (S-Anxiety)

    State anxiety will be assessed using the STAI State subscale (S-Anxiety), a validated 20-item self-report tool. Items are rated on a 4-point Likert scale, with total scores ranging from 20 to 80. Higher scores indicate greater levels of state anxiety.

    Time frame: Baseline (immediately before IUD insertion) and immediately after the procedure

07

Study locations

1 site
  • Tanta University Hospital
    Tanta, 74322, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07648134
Lead sponsor
Tanta University
Responsible party
Dr. Manal Abdelaziz (Manal Mohammed Ahmed Abdelaziz, Tanta University) — Principal investigator
First posted
Jun 15, 2026
Start date
Sep 1, 2022
Primary completion
Mar 1, 2023
Completion
Mar 30, 2023
Last update
Jun 15, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion